Danita M. Yoerger Sanborn, M.D.
This page shows the publications co-authored by Danita Sanborn and Igor Palacios.
Delgado G, Inglessis I, Martin-Herrero F, Yoerger D, Liberthson R, Buoanno F, Palacios I. Management of platypnea-orthodeoxia syndrome by transcatheter closure of atrial communication: hemodynamic characteristics, clinical and echocardiographic outcome. J Invasive Cardiol. 2004 Oct; 16(10):578-82.
Fifer MA, Yoerger DM, Picard MH, Vlahakes GJ, Palacios IF. Images in cardiovascular medicine. Covered stent septal ablation for hypertrophic obstructive cardiomyopathy: initial success but ultimate failure resulting from collateral formation. Circulation. 2003 Jul 01; 107(25):3248-9.
Lowe HC, Jang IK, Yoerger DM, MacGillivray TE, de Moor M, Palacios IF. Compassionate use of the amplatzer ASD closure device for residual postinfarction ventricular septal rupture following surgical repair. Catheter Cardiovasc Interv. 2003 Jun; 59(2):230-3; discussion 234.
Jassal DS, Neilan TG, Fifer MA, Palacios IF, Lowry PA, Vlahakes GJ, Picard MH, Yoerger DM. Sustained improvement in left ventricular diastolic function after alcohol septal ablation for hypertrophic obstructive cardiomyopathy. Eur Heart J. 2006 Aug; 27(15):1805-10.
Jassal DS, Neilan TG, Fatima U, Holmvang G, Agnihotri A, Palacios I, Yoerger DM. Mitral valve ring dehiscence with an aorta-left atrial fistula. Eur J Echocardiogr. 2007 Aug; 8(4):296-8.
Yoerger DM, Picard MH, Palacios IF, Vlahakes GJ, Lowry PA, Fifer MA. Time course of pressure gradient response after first alcohol septal ablation for obstructive hypertrophic cardiomyopathy. Am J Cardiol. 2006 May 15; 97(10):1511-4.
Chen AA, Palacios IF, Mela T, Yoerger DM, Picard MH, Vlahakes G, Lowry PA, Fifer MA. Acute predictors of subacute complete heart block after alcohol septal ablation for obstructive hypertrophic cardiomyopathy. Am J Cardiol. 2006 Jan 15; 97(2):264-9.
Rothman RD, Baggish AL, O'Callaghan C, Lowry PA, Bhatt AB, MacRae CA, Yannekis G, Sanborn DM, Mela T, Yeh RW, Palacios I, Vlahakes GJ, Fifer MA. Management strategy in 249 consecutive patients with obstructive hypertrophic cardiomyopathy referred to a dedicated program. Am J Cardiol. 2012 Oct 15; 110(8):1169-74.
Noseworthy PA, Rosenberg MA, Fifer MA, Palacios IF, Lowry PA, Ruskin JN, Sanborn DM, Picard MH, Vlahakes GJ, Mela T, Das S. Ventricular arrhythmia following alcohol septal ablation for obstructive hypertrophic cardiomyopathy. Am J Cardiol. 2009 Jul 01; 104(1):128-32.
Delling FN, Sanborn DY, Levine RA, Picard MH, Fifer MA, Palacios IF, Lowry PA, Vlahakes GJ, Vaturi M, Hung J. Frequency and mechanism of persistent systolic anterior motion and mitral regurgitation after septal ablation in obstructive hypertrophic cardiomyopathy. Am J Cardiol. 2007 Dec 01; 100(11):1691-5.
Baggish AL, Smith RN, Palacios I, Vlahakes GJ, Yoerger DM, Picard MH, Lowry PA, Jang IK, Fifer MA. Pathological effects of alcohol septal ablation for hypertrophic obstructive cardiomyopathy. Heart. 2006 Dec; 92(12):1773-8.
The connection strength for co-authors is the sum of the scores for each of their shared publications.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.